EXACT SCIENCES (NASDAQ: EXAS) In our first distributed deep dive, we share our research into a leading healthcare stock at the cutting edge of early cancer screening. With an exciting pipeline of products and a strong track record of growth, we believe Exact Sciences presents a fascinating investment opportunity for retail investors looking to capitalize on the healthcare industry’s potential.